No Data
No Data
Express News | U.S.-Listed Shares of CRISPR Therapeutics Fall 10.3%, Sarepta Therapeutics Fall 20.2%
Express News | Taysha Gene Therapies Fall 19%, Solid Biosciences Fall 11.4%, Capricor Therapeutics Fall 18%
Express News | Gene Therapy Makers Fall After US FDA Names Oncologist Vinay Prasad as Top Vaccine Official
Solid Biosciences to Present at the American Society of Gene and Cell Therapy's 28th Annual Meeting
Piper Sandler Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $20
$SLDB Stock Is up 11% Today. Here's What We See in Our Data.
carlton griffiths OP : they shook the
almost bailed
lets
